Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC

NCT05209256 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Chemotherapy
DRUG: Alflutinib plus chemotherapy

Sponsor

The First Affiliated Hospital of Henan University of Science and Technology